Federal contractor profile
AmerisourceBergen Drug: Federal Contracts, Agencies & Awards
Data through 2026-09-28 · FY2026 to date
- Obligations, FY2026 to date
- $6B
- Contract awards
- 385,562
- Average award size
- $15.5K
- vs. prior full fiscal year
- 19.9% decline
| Item | Obligations |
|---|---|
| FY21 | $2.1B |
| FY22 | $2B |
| FY23 | $4.4B |
| FY24 | $6.1B |
| FY25 | $7.4B |
| FY26 | $6B |
Obligations fell 19.9% year over year, from $7.4B in FY2025 to $6B in FY2026 to date.
AmerisourceBergen Drug obligated $6B in FY2026 to date through federal contracts. The company won 385,562 awards with an average award size of $15.5K. Obligations are down 19.9% year over year. Fiscal-year history shows obligations of $2.1B in FY21, $2B in FY22, $4.4B in FY23, $6.1B in FY24, and $7.4B in FY25. The Department of Defense is the dominant buyer, obligating $6B in the current fiscal year to date. Medicinal and Botanical Manufacturing is the largest NAICS market for AmerisourceBergen Drug with $4B, followed by Drugs and Druggists' Sundries Merchant Wholesalers at $2B and Pharmaceutical Preparation Manufacturing at $639K. Current-year totals are partial and reported as fiscal year to date. Award-value totals in the largest-awards and expiring-contracts tables are total contract values rather than obligations.
How is AmerisourceBergen Drug's federal business performing?
AmerisourceBergen Drug obligated $6B in FY2026 to date and won 385,562 awards with an average award size of $15.5K. Obligations are down 19.9% year over year. Fiscal-year obligations rose from $2.1B in FY21 and $2B in FY22 to $4.4B in FY23, $6.1B in FY24, and $7.4B in FY25 before the current-year total of $6B.
| Item | Obligations |
|---|---|
| Department of Defense | $6B |
| Department of Veterans Affairs | $639K |
| Department of Justice | $28K |
Department of Defense is AmerisourceBergen Drug's largest federal customer, with $6B obligated (100.0% of the company's federal obligations).
Who are the top buyers and what markets dominate AmerisourceBergen Drug's contracts?
The Department of Defense obligated $6B for AmerisourceBergen Drug in FY2026 to date, with the Department of Veterans Affairs at $639K and the Department of Justice at $28K. Medicinal and Botanical Manufacturing accounts for $4B, Drugs and Druggists' Sundries Merchant Wholesalers account for $2B, and Pharmaceutical Preparation Manufacturing accounts for $639K.
| Item | Obligations |
|---|---|
| Medicinal and Botanical Manufacturing | $4B |
| Drugs and Druggists' Sundries Merchant Wholesalers | $2B |
| Pharmaceutical Preparation Manufacturing | $639K |
Medicinal and Botanical Manufacturing is AmerisourceBergen Drug's largest federal market, with $4B in obligations.
| Rank | Award | Award Amount | Awarding Agency | Ends |
|---|---|---|---|---|
| 1 | SPE2DR26FTK1X | $9M | Department of Defense | 2026-03-12 |
| 2 | SPE2DR26FTP0K | $7.7M | Department of Defense | 2026-06-15 |
| 3 | SPE2DR26FTJ2Z | $7.7M | Department of Defense | 2026-01-20 |
| 4 | SPE2D826F1G47 | $5.2M | Department of Defense | 2026-02-19 |
| 5 | SPE2D826F0DPT | $4.9M | Department of Defense | 2026-02-04 |
| 6 | SPE2D826F10Z9 | $4.8M | Department of Defense | 2026-02-19 |
| 7 | SPE2D826F2A54 | $4.5M | Department of Defense | 2026-05-14 |
| 8 | SPE2D826F09G3 | $4.3M | Department of Defense | 2026-02-03 |
| 9 | SPE2D826F17U3 | $4.3M | Department of Defense | 2026-05-14 |
| 10 | SPE2D826F2D63 | $4.2M | Department of Defense | 2026-05-29 |
| 11 | SPE2D826F1C24 | $4.2M | Department of Defense | 2026-02-04 |
| 12 | SPE2D826F18X5 | $4.1M | Department of Defense | 2026-05-29 |
| 13 | SPE2D826F09V0 | $4M | Department of Defense | 2026-02-04 |
| 14 | SPE2D826F16P5 | $4M | Department of Defense | 2026-04-30 |
| 15 | SPE2D826F0Y96 | $4M | Department of Defense | 2026-01-15 |
| 16 | SPE2D826F0N62 | $3.9M | Department of Defense | 2025-11-28 |
| 17 | SPE2D826F1P86 | $3.9M | Department of Defense | 2026-03-26 |
| 18 | SPE2D826F1A55 | $3.9M | Department of Defense | 2026-01-22 |
| 19 | SPE2D826F0T03 | $3.8M | Department of Defense | 2025-12-19 |
| 20 | SPE2D826FA3EF | $3.8M | Department of Defense | 2026-01-06 |
| 21 | SPE2D826F1X62 | $3.7M | Department of Defense | 2026-04-30 |
| 22 | SPE2D826F04N1 | $3.7M | Department of Defense | 2025-11-28 |
| 23 | SPE2D826F0X37 | $3.7M | Department of Defense | 2026-01-08 |
| 24 | SPE2D826F08M4 | $3.6M | Department of Defense | 2026-01-15 |
| 25 | SPE2D826F13U5 | $3.6M | Department of Defense | 2026-03-26 |
This is the free layer.
GovHub customers get the live version, filters, exports, and AI proposal drafting on top of this data.
No credit card required · 14-day free trial
Frequently asked questions
How much does AmerisourceBergen Drug make from federal contracts?
AmerisourceBergen Drug makes $6B from federal contract obligations in FY2026 to date. The company won 385,562 awards in the current fiscal year to date with an average award size of $15.5K. Obligations are down 19.9% year over year.
Which agencies buy from AmerisourceBergen Drug?
The Department of Defense buys most from AmerisourceBergen Drug, obligating $6B in FY2026 to date. The Department of Veterans Affairs bought $639K and the Department of Justice bought $28K in the current fiscal year to date.
What does AmerisourceBergen Drug sell to the government?
AmerisourceBergen Drug sells primarily in Medicinal and Botanical Manufacturing and related pharmaceutical markets to the government, with $4B in that NAICS market and $2B in Drugs and Druggists' Sundries Merchant Wholesalers. Pharmaceutical Preparation Manufacturing accounted for $639K in FY2026 to date.
Which AmerisourceBergen Drug contracts are expiring soon?
No expiring-contract dollar totals are listed for AmerisourceBergen Drug in the provided facts. The dataset does not include specific expiring-contract figures.
Found your market? GovHub writes the proposal.
Turn this market intelligence into a submitted, compliant federal proposal, faster.
No credit card required · 14-day free trial